For GBM, mostly studied target genes of siRNA included oncogenes, cytokine receptors and key signaling regulators, such as BCL2, SIRT2, GAL1, c-Met, EGFR, BAG3 and PLK1 [8]. This evidence concerns the gene PLK1 and glioblastoma.